Congress · Boston, Massachusetts
World Drug Safety Congress Americas 2013
Biotechnology · Health · Business consulting
Key numbers
- Editions on record
- 6first in 2009
About World Drug Safety Congress Americas
Developing and implementing the right drug safety strategy is one of the most pressing challenges facing
the biopharmaceutical industry today.
The 5th annual World Drug Safety Congress provides you with key insights into the drug safety challenges affecting you and gives you an excellent opportunity to discuss these diverse issues in a conference format.
Focus on...
• International drug safety landscape
• Global regulatory overview and recent developments
• Increasing complexities affecting the management of drug safety
• Data management and electronic submissions
• Financial and logistical constraints
• In-depth look at clinical safety & the limitations to pre-marketing safety
Speakers
David Balderson,Paul Beninger,Cristina Damatarca MD,Peter de Veene,
Reinerio Deza,Hoda Eid, M.Sc., Ph.D.,Michael Forstner,Stephen Furlong,
Robin Geller and many more.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2015 | 24–25 Apr 2015 | Revere Hotel – Boston Common Boston, Massachusetts | — | — |
| 2014 | 8–11 Apr 2014 | Revere Hotel – Boston Common Boston, Massachusetts | — | — |
| 2013 | 24–25 Apr 2013 | Hyatt Regency Boston Boston, Massachusetts | — | — |
| 2012 | 17–20 Apr 2012 | Hyatt Regency Boston Boston, Massachusetts | — | — |
| 2011 | 12–15 Apr 2011 | Hyatt Regency Boston Boston, Massachusetts | — | — |
| 2010 | 15 Apr 2010 | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.